TORONTO (Reuters) – The Canadian government announced final regulations on Friday that should cut billions of dollars from patented drug prices that are among the highest in the world, overcoming heavy opposition from pharmaceutical companies who may eventuall... More »
LONDON (Reuters) – Doing things one at a time in drug development is not a luxury that GlaxoSmithKline can afford any longer, the head of pharmaceuticals at Britain’s largest drugmaker told Reuters. Luke Miels, who joined GSK in September 2017 after a contract... More »
LONDON (Reuters) – A number of high blood pressure and heart drugs containing an ingredient made in China are being recalled across Europe after an impurity that may cause cancer was found in them, officials said on Thursday. The European Medicines Agency said... More »
BRUSSELS (Reuters) – The European Commission on Monday proposed to change intellectual property rules to let pharmaceutical companies produce generic drugs for export to countries and regions where they are not under extended patent protection. Supplementary p... More »
(Reuters) – U.S. Food and Drug Administration chief Scott Gottlieb on Thursday questioned whether rebates that drugmakers provide to health insurers should remain protected by federal law, sparking new concerns on Wall Street over efforts to curb drug pricing.... More »
LONDON (Reuters) – In London’s world-famous Great Ormond Street children’s hospital, Dr. Karin Straathof is excited about a new cell-based medicine that offers hope for toddlers with incurable nerve tissue cancer. Her progress with a handful of children for wh... More »
NEW YORK (Reuters) – Allergan Plc on Friday announced positive results from a second Phase III trial for the 50 milligram dose of its drug for acute migraine, reproducing results from the previous trial. A lower dose of the drug, ubrogepant, failed to meet one... More »
FILE PHOTO: A surgery nurse is seen beside the heart beat monitor in the operating theatre of the Unfallkrankenhaus Berlin (UKB) hospital in Berlin, Germany February 29, 2008. REUTERS/Fabrizio Bensch /File Photo LONDON (Reuters) – Drugmakers are racing to scoo... More »
LEVERKUSEN, Germany (Reuters) – Bayer is seeking to defend its pharmaceuticals business that will be diluted in importance by the takeover of Monsanto and faces a threat to revenues in 2024 when the blockbuster heart drug Xarelto loses its patent. The firm’s p... More »
China is looking to speed up approvals for new drugs and plans to accept data from clinical trials carried out overseas, a potential boon for international drugmakers and patients who often face lengthy delays for new medicines to reach the market. More »
The British government has rekindled its industrial strategy, unveiled earlier this year to prepare the economy for Brexit, with plans to boost the country's pharmaceuticals sector via fresh investments and public-private collaborations. More »
An employee inspects tablets as they move along the production line at a pharmaceutical plant of Lupin, India’s No. 2 drugmaker, in Verna, in the western state of Goa, India, June 9, 2017. Picture taken June 9, 2017. REUTERS/Danish Siddiqui In 28 years in Indi... More »
The main U.S. trade group for generic pharmaceutical companies filed a lawsuit on Thursday seeking to block a recently adopted Maryland law that lets the state attorney general sue generic drugmakers that sharply raise prices. More »
FILE PHOTO: Signage for GlaxoSmithKline is seen on its offices in London, Britain, March 30, 2016. REUTERS/Toby Melville/File Photo The world’s leading drug companies are turning to artificial intelligence to improve the hit-and-miss business of finding new me... More »
FILE PHOTO – A view shows the U.S. Food and Drug Administration (FDA) headquarters in Silver Spring, Maryland August 14, 2012. REUTERS/Jason Reed/File Photo The number of new drugs approved for sale in United States and Europe has bounced back this year, sugge... More »
The logo of Swiss pharmaceutical company Roche is seen outside their headquarters in Basel, January 30, 2014. REUTERS/Ruben Sprich/File Photo A person in Germany treated with Roche Holding AG’s new multiple sclerosis drug Ocrevus has been diagnosed with an oft... More »
Pharmaceutical companies called on Thursday for a phased transition in drug regulation after Britain leaves the European Union, in order to avoid supply disruption and protect public health. More »
Guido Rasi, executive director the European Medicines Agency (EMA), poses for a portrait at his office in London, Britain, January 6, 2012. REUTERS/Finbarr O’Reilly/File Photo Europe’s drugmakers pushed for a decision as early as June on the new location for t... More »
A man talks on the phone near a sign for the reception office of China’s Food and Drug Administration in Beijing, China, May 17, 2016. REUTERS/Damir Sagolj China is considering taking measures that will shorten the time to market for approved imported drugs in... More »
The Finnish government on Friday said it will join several other European Union states in bidding to become the new home of the European Medicines Agency (EMA) once Britain leaves the EU. More »
Shelves displaying medicines are seen at a pharmacy in Shanghai, China November 27, 2015. REUTERS/Aly Song/File Photo China has updated list of medicines covered by basic medical insurance schemes, a long-awaited fillip for drugmakers in the world’s second-lar... More »
FILE PHOTO: Packets of Herceptin sit on a pharmacy shelf in London, Britiain, June 9, 2006. REUTERS/Luke MacGregor/File Photo Treatment with two important cancer drugs is about to get much cheaper in Europe with a cut-price copy of Roche’s blood cancer drug Ri... More »
FILE PHOTO: U.S. President-elect Donald Trump speaks at his election night rally in Manhattan, New York, U.S., November 9, 2016. REUTERS/Carlo Allegri/File Photo President Donald Trump supports the government negotiating directly with drug companies on prices ... More »
European prices for some off-patent cancer drugs have risen by more than 100 percent in the past five years, with two cases of hikes exceeding 1,000 percent, according to data presented at a medical conference on Saturday. More »
A person holds pharmaceutical tablets and capsules in this picture illustration taken in Ljubljana September 18, 2013. REUTERS/Srdjan Zivulovic Last year turned out to be a disappointing one for new drug approvals with the U.S. Food and Drug Administration cle... More »
An artificial leaf designed by scientists at Eindhoven University of Technology, Netherlands December 16, 2016. REUTERS/Jim Drury Dutch scientists have developed an artificial leaf that can act as a mini-factory for producing drugs, an advance that could allow... More »
Two U.S. lawmakers are questioning whether Heritage Pharmaceuticals misled them in response to a 2014 congressional inquiry about the rising price a common antibiotic, after 20 U.S. states this week accused the company of price fixing. More »
Signage for GlaxoSmithKline is seen on it’s offices in London, Britain, March 30, 2016. REUTERS/Toby Melville/File Photo The world’s top drugmakers have improved access to medicines in developing countries but still need to do more to make a wider range of pro... More »
U.S. Democratic presidential nominee Hillary Clinton listens as U.S. Senator Bernie Sanders speaks about college affordability during a campaign event at the University of New Hampshire in Durham, New Hampshire, United States September 28, 2016. REUTERS/Brian ... More »
Big pharmaceutical companies are waging courtroom patent battles against each other over biosimilars, as the line blurs between companies known for their inn More »
An Amgen sign is seen at the company’s office in South San Francisco, California in this October 21, 2013 file photo. REUTERS/Robert Galbraith/Files The line dividing makers of brand-name drugs and copycat medicines is blurring as companies known for innovativ... More »
SHANGHAI China’s drug regulator said it would accelerate approvals of new medicines, long a headache for pharmaceutical firms who complain it takes too long to get drugs to market. The China Food and Drug Administration (CFDA) said in a statement published on ... More »
NEW YORK The tumble in share prices for biotechnology stocks has created some buying opportunities, with drugmakers Celgene Corp (CELG.O) and Gilead Sciences (GILD.O) poised for a 30 percent rise over the next year, Barron’s said. Both companies currently rely... More »
SHANGHAI China, already a global powerhouse in high-tech areas from solar panels to bullet trains, is turning its industrial might to the challenge of making more of its own drugs for a vast and aging population. Given the 10 years or more it typically takes t... More »
LONDON British pharmaceutical and biotechnology companies face a major skills shortage which threatens future investment and the long-term success of the life sciences sector, according to a new industry report. The Association of the British Pharmaceutical In... More »
LONDON Three of Europe’s top drugmakers – GlaxoSmithKline, Roche and Sanofi – face health checks this week at high-profile presentations designed to show they can overcome looming market threats. The unusual confluence of investor days comes at a testing time ... More »
